- 1 May 1992
- journal article
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.The Journal of Experimental Medicine, 1985
- LY-1+2- SUPPRESSOR T CELLS INHIBIT THE EXPRESSION OF PASSIVELY TRANSFERRED ANTITUMOR IMMUNITY BY SUPPRESSING THE GENERATION OF CYTOLYTIC T CELLSTransplantation, 1985
- Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo.The Journal of Immunology, 1984
- Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.The Journal of Immunology, 1983
- Characterization of T lymphocytes mediating in vivo protection against RSV‐induced murine sarcomasInternational Journal of Cancer, 1983
- Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.The Journal of Experimental Medicine, 1981
- Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens*Immunological Reviews, 1979
- Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures.Journal of Biological Chemistry, 1975
- ANTIGENIC PROPERTIES OF CHEMICALLY INDUCED TUMORS*Annals of the New York Academy of Sciences, 1962
- A modified uronic acid carbazole reactionAnalytical Biochemistry, 1962